Autofluorescence as indicator for detecting the surgical margins of medication-related osteonecrosis of the jaws

Minerva Stomatol. 2016 Aug;65(4):248-52.

Authors

Ilaria Giovannacci¹, Marco Meleti, Maddalena Manfredi, Elisabetta Merigo, Carlo Fornaini, Mauro Bonanini, Paolo Vescovi

Affiliation

¹ Center of Oral Pathology and Laser Surgery, Department of Biomedical, Biotechnological and Translational Sciences, University of Parma, Parma, Italy - ilaria.giovannacci@gmail.com.

PMID: 27374363

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Aged, 80 and over
Bicuspid / surgery
Bisphosphonate-Associated Osteonecrosis of the Jaw / pathology
Bisphosphonate-Associated Osteonecrosis of the Jaw / surgery*
Bone Neoplasms / drug therapy
Bone Neoplasms / secondary
Breast Neoplasms / pathology
Cementoplasty
Diphosphonates / adverse effects*
Diphosphonates / therapeutic use
Female
Follow-Up Studies
Humans
Imidazoles / adverse effects*
Imidazoles / therapeutic use
Laser Therapy*
Lasers, Solid-State / therapeutic use
Lung Neoplasms / pathology
Male
Margins of Excision*
Middle Aged
Multiple Myeloma / drug therapy
Optical Imaging*
Postoperative Complications / pathology
Postoperative Complications / surgery
Tooth Extraction
Zoledronic Acid

Substances

Diphosphonates
Imidazoles
Zoledronic Acid